The Food and Drug Administration’s recent announcement approving Pfizer’s treatment for hemophilia B marks a significant milestone in the field of gene therapy. The drug, known as Beqvez, is the first gene therapy from Pfizer to receive clearance in the U.S., offering new hope for adults with moderate to severe hemophilia B. Beqvez is a
Rare
Walgreens recently announced its plans to partner directly with drugmakers to provide cell and gene therapies to patients in the United States. This initiative is part of a broader expansion of the company’s specialty pharmacy services. The establishment of a new business unit dedicated to the specialty pharmacy segment, which includes AllianceRx as a subsidiary,
Looking for rare and lucrative online income streams? Discover innovative platforms and untapped market niches that will revolutionize your digital entrepreneurship journey.